FDA's "Entrepreneurs-In-Residence" Program Aims To Help Small Companies
Executive Summary
New FDA measures aimed at helping small businesses navigate the regulatory review process are part of the agency’s larger counter-attack against claims that it is creating a drag on medical product innovation.
You may also be interested in...
Hamburg Says Rhetoric Over FDA's Effect On Innovation Could Harm Regulatory Process
In a speech to the consumer group Public Citizen, FDA Commissioner Margaret Hamburg says the increasingly heated complaints that the agency is stifling medical product development could undermine public confidence in regulatory standards and approved products.